Moreover, TNC induces CCL21 in LECs (through α9β1 integrin), as well as its receptor CCR7 (through TLR4) on several types of leukocytes, thereby likely promoting their activation and entry into the tumor through lymphatic vessels (Spenlé et al., 2020). The gene discussed is CCL21; the disease is neoplasm.